Three hundred forty-five thousand doses of Bivalent, the new vaccine produced by Pfizer have arrived in Nepal, under COVAX facility.
Surendra Chaurasiya, Chief of Supply Management Division, Department of Health Services, said that the vaccine arrived at 9 am on Monday.
According to him, the vaccine received through GAVI would be stored at the Department at Teku. The Bivalent vaccine which has entered Nepal for the first time will be used as booster dose.
A bivalent COVID-19 vaccine may also be referred to as “updated” COVID-19 vaccine booster dose.These are called bivalent COVID-19 vaccines because they contain a component of the original virus strain to provide broad protection against COVID-19 and a component of the omicron variant to provide better protection against COVID-19 caused by the omicron variant. Hence, considered effective against the Omicron sub-variant of the Corona Virus.
A total 1.5 million doses of the Bivalent vaccine would be provided to Nepal under the COVAX facility in four phases and accordingly the 345 thousand doses of the vaccine have been brought today.
Comprehensive Data Protection Law Critically
Gender Differences In Mental Healthcare
Messi Wins Best FIFA Men’s
Erosion of Democracy
Fly Dubai Catches Fire in
“Complexities of the South Asian